War and Disease, Biomedical Research on Malaria in the Twentieth Century

Peter Neushul

Social History of Medicine · 2009 · 15 citations · 0 references

Concepts

Abstract

Leo Slater's War and Disease examines work on anti-malarial drugs during the Second World War. Slater worked as a pharmaceutical research chemist before completing a doctorate in history at Princeton University. He is a fellow at the Johns Hopkins University's Institute for Applied Economics and the Study of Business Enterprise specialising in twentieth-century biomedicine, science and technology. Slater's previous work on malaria includes an article which appeared within the Bulletin of the History of Medicine (2005) and constitutes a chapter in War and Disease. Slater's slim eight-chapter volume begins with a concise history of quinine. He then focuses on the interwar years and the development of methods for testing anti-malarial drugs in birds. Research at German chemical companies led to the first generation of synthetic anti-malarials, providing alternatives to the quinine monopoly during the 1930s. Chapters four, five and six are set in the Second World War and describe the US National Research Council (NRC) effort to promote scientific research on malaria chemotherapy and the eventual implementation of a research agenda by the Office of Scientific Research and Development's Committee on Medical Research (CMR). According to Slater, the CMR developed two significant drugs; pentaquine and chloroquine. In the immediate post-war era, Slater describes the emergence of chloroquine as a ‘Wonder Drug’ for malaria treatment and prophylaxis. He concludes with an assessment of lessons learned from the Second World War research programme and continued research on anti-malarials in the post-war era.